Filing Details
- Accession Number:
- 0001209191-24-005061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-22 16:52:02
- Reporting Period:
- 2024-03-20
- Accepted Time:
- 2024-03-22 16:52:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1658247 | Crinetics Pharmaceuticals Inc. | CRNX | Pharmaceutical Preparations (2834) | 263744114 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1948238 | Dana Pizzuti | C/O Crinetics Pharmaceuticals, Inc. 6055 Lusk Boulevard San Diego CA 92121 | Chief Med And Dev Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-20 | 4,375 | $16.89 | 32,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-20 | 4,375 | $45.89 | 28,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-03-20 | 10,000 | $16.89 | 38,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-20 | 10,000 | $43.28 | 28,500 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-20 | 714 | $43.69 | 27,786 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-03-20 | 4,375 | $0.00 | 4,375 | $16.89 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-03-20 | 10,000 | $0.00 | 10,000 | $16.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 201,667 | 2032-10-10 | No | 4 | M | Direct | |
| 191,667 | 2032-10-10 | No | 4 | M | Direct |
Footnotes
- The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.28 per share. The range of sales prices on the transaction date was $42.70 to $43.77 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
- The option is exercisable as follows: 25% of the shares subject to the option vest on September 30, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Billionaire Hedge Funds
